Common Contracts

SEPARATION AND DISTRIBUTION AGREEMENT among APP PHARMACEUTICALS, INC. (f/k/a GENERICO HOLDINGS, INC.) APP PHARMACEUTICALS, LLC ABRAXIS BIOSCIENCE, LLC and NEW ABRAXIS, INC. (to be renamed ABRAXIS BIOSCIENCE, INC.) Dated as of November 13, 2007

Separation and Distribution Agreement • March 17th, 2008 • APP Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware

• Contract Type
  Separation and Distribution Agreement
• Filed
  March 17th, 2008
• Company
  APP Pharmaceuticals, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

This SEPARATION AND DISTRIBUTION AGREEMENT (this “Agreement”), dated as of November 13th, 2007, is among APP Pharmaceuticals, Inc., a Delaware corporation formerly known as Generico Holdings, Inc. (“Gholdco”), APP Pharmaceuticals, LLC, a Delaware limited liability company (“Generico”) (Gholdco and Generico, together, the “Generico Parties”), Abraxis BioScience, LLC, a Delaware limited liability company (“New Alpha, LLC”), and New Abraxis, Inc., a Delaware corporation (to be renamed Abraxis BioScience, Inc.) (“New Alpha”) (New Alpha, LLC and New Alpha, together, the “Alpha Parties”).

SEPARATION AND DISTRIBUTION AGREEMENT among APP PHARMACEUTICALS, INC. (f/k/a GENERICO HOLDINGS, INC.) APP PHARMACEUTICALS, LLC ABRAXIS BIOSCIENCE, LLC and NEW ABRAXIS, INC. (to be renamed ABRAXIS BIOSCIENCE, INC.) Dated as of November 13, 2007

Separation and Distribution Agreement • December 20th, 2007 • Abraxis Biosciences, Inc. • Pharmaceutical preparations • Delaware

• Contract Type
  Separation and Distribution Agreement
• Filed
  December 20th, 2007
• Company
  Abraxis Biosciences, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

This SEPARATION AND DISTRIBUTION AGREEMENT (this “Agreement”), dated as of November 13th, 2007, is among APP Pharmaceuticals, Inc., a Delaware corporation formerly known as Generico Holdings, Inc. (“Gholdco”), APP Pharmaceuticals, LLC, a Delaware limited liability company (“Generico”) (Gholdco and Generico, together, the “Generico Parties”), Abraxis BioScience, LLC, a Delaware limited liability company (“New Alpha, LLC”), and New Abraxis, Inc., a Delaware corporation (to be renamed Abraxis BioScience, Inc.) (“New Alpha”) (New Alpha, LLC and New Alpha, together, the “Alpha Parties”).

FORM OF SEPARATION AND DISTRIBUTION AGREEMENT among ABRAXIS BIOSCIENCE, INC. (f/k/a GENERICO HOLDINGS, INC. to be renamed APP PHARMACEUTICALS, INC.) NEW APP LLC NEW ABRAXIS, LLC and NEW ABRAXIS, INC. (to be renamed ABRAXIS BIOSCIENCE, INC.) Dated as...

Separation and Distribution Agreement • October 5th, 2007 • New Abraxis, Inc. • Pharmaceutical preparations • Delaware

• Contract Type
  Separation and Distribution Agreement
• Filed
  October 5th, 2007
• Company
  New Abraxis, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

This SEPARATION AND DISTRIBUTION AGREEMENT (this “Agreement”), dated as of , 2007, is among Abraxis BioScience, Inc., a Delaware corporation formerly known as Generico Holdings, Inc. (to be renamed APP Pharmaceuticals, Inc.) (“Gholdco”), New APP LLC, a Delaware limited liability company (“Generico”) (Gholdco and Generico, together, the “Generico Parties”), New Abraxis, LLC, a Delaware limited liability company (“New Alpha LLC”), and New Abraxis, Inc., a Delaware corporation (to be renamed Abraxis BioScience, Inc.) (“New Alpha”) (New Alpha LLC and New Alpha, together, the “Alpha Parties”).